AIHOT 于 2026-08-18 收录了“JAMA 评论文章：AI 超越医生时，监管者不应强制人类介入”这一公开动态。以下先呈现从来源页面抓取的正文，再给出 AIHOT 摘要与 TopoReduce 编辑解读。
PUBLIC SOURCE CONTENT
已抓取公开正文公开原文内容
As AI beats doctors, regulators shouldn't force a human into the loop, JAMA piece says
As AI beats doctors, regulators shouldn't force a human into the loop, JAMA piece says
Maximilian Schreiner
View the LinkedIn Profile of Maximilian Schreiner
Aug 18, 2026
Nano Banana Pro prompted by THE DECODER
An opinion piece in the medical journal JAMA predicts that autonomous AI will outperform any doctor-AI pairing at medical reasoning. The authors want to stop regulators from writing a human in the loop into the rules.
Knowing who wrote the JAMA piece helps explain its angle: Lead author Ezekiel Emanuel is a bioethicist at the University of Pennsylvania and one of the architects of Obama's healthcare reform, making him a heavyweight in US health policy. Coauthor Neal Khosla is CEO of the AI telemedicine company Curai Health, and his father, Vinod Khosla, is an investor in both OpenAI and Curai Health. Two of the authors stand to gain directly from the future the piece champions.
That future clashes with the position held by physician groups like the American Medical Association and the American College of Physicians, which say AI should support doctors, never replace them. Medical professor Robert Wachter goes further in his book, calling AI-only care the "economy class" of medicine. The JAMA authors consider this ranking unproven and offer two arguments against it.
The first concerns the research. In most studies since 2024, AI on its own matches or beats doctors at the five core reasoning tasks of medicine, namely taking a patient history, making diagnoses, choosing tests, treating according to guidelines, and managing chronic disease.
Google's conversational system AMIE scored higher than primary care doctors in almost every category during simulated patient conversations. Across 377 complex cases, ChatGPT o3 named the correct diagnosis first 60 percent of the time, compared with 15.9 percent for 20 internists. Microsoft's diagnostic orchestrator found the correct diagnosis under budget constraints about four times as often as doctors, at lower cost. The authors dismiss most studies with the opposite finding as outdated or methodologically weak, for example because they left out the best models.
The second argument is a forecast about where things are headed, and it forms the heart of the piece. The models are improving fast, while doctors lose their own skills through AI use, as a Lancet study on colonoscopies suggests. The gap should only widen from here.
Once the machine is clearly ahead, the doctor doing the checking turns from a safety net into a source of error. According to the authors, a meta-analysis of 106 experiments backs this up. When the human is better, the combination helps. When the AI is better, the human makes the result worse by overruling the system in the wrong places. In a study using real patient cases, GPT-4 alone scored 92 percent on diagnostic reasoning, while doctors with access to the same model scored just 76 percent.
The authors use chess as a historical parallel: After Deep Blue beat Kasparov in 1997, human-machine teams dominated for years, until AI began beating the teams too starting in 2017.
A warning to the rule writers
From this the piece draws its real message: Locking in guidelines that require a doctor to make the final call could cement a form of care that will soon fall behind. By 2030, the authors expect autonomous AI to be ready for some, maybe many, workflows, limited to cognitive tasks. Liability, payment, regulation, and medical training all need a rethink now, they argue.
There are however limitations to their message, as they admit. Almost all the evidence comes from simulations of single tasks, not real patient care, and the handoff of information between human and model counts as a weak spot.
Physical procedures like surgery, childbirth, and colonoscopies will also stay with humans for now, since the robotics aren't up to it. And autonomous systems fail in ways doctors don't, through hallucinations, internet outages, or cyberattacks. Those risks have to be weighed against the higher accuracy, the authors concede.
AI News Without the Hype – Curated by Humans
Subscribe to THE DECODER for ad-free reading, a weekly AI newsletter, our exclusive "AI Radar" frontier report six times a year, full archive access, and access to our comment section.
Subscribe now
Read on for the full picture.
Subscribe for hype-free coverage.
- Full access to every article on THE DECODER
- No ads
- Join the comments and community discussions
- A weekly AI news recap via mail
- 6x/year: "AI Radar" — deep dives on the AI topics that matter most
- Daily AI news, always up to date
- Our full ten-year archive
- Covered by a team with 10+ years in AI
Subscribe to The Decoder
Maximilian Schreiner
View the LinkedIn Profile of Maximilian Schreiner
Aug 18, 2026
Nano Banana Pro prompted by THE DECODER
An opinion piece in the medical journal JAMA predicts that autonomous AI will outperform any doctor-AI pairing at medical reasoning. The authors want to stop regulators from writing a human in the loop into the rules.
Knowing who wrote the JAMA piece helps explain its angle: Lead author Ezekiel Emanuel is a bioethicist at the University of Pennsylvania and one of the architects of Obama's healthcare reform, making him a heavyweight in US health policy. Coauthor Neal Khosla is CEO of the AI telemedicine company Curai Health, and his father, Vinod Khosla, is an investor in both OpenAI and Curai Health. Two of the authors stand to gain directly from the future the piece champions.
That future clashes with the position held by physician groups like the American Medical Association and the American College of Physicians, which say AI should support doctors, never replace them. Medical professor Robert Wachter goes further in his book, calling AI-only care the "economy class" of medicine. The JAMA authors consider this ranking unproven and offer two arguments against it.
The first concerns the research. In most studies since 2024, AI on its own matches or beats doctors at the five core reasoning tasks of medicine, namely taking a patient history, making diagnoses, choosing tests, treating according to guidelines, and managing chronic disease.
Google's conversational system AMIE scored higher than primary care doctors in almost every category during simulated patient conversations. Across 377 complex cases, ChatGPT o3 named the correct diagnosis first 60 percent of the time, compared with 15.9 percent for 20 internists. Microsoft's diagnostic orchestrator found the correct diagnosis under budget constraints about four times as often as doctors, at lower cost. The authors dismiss most studies with the opposite finding as outdated or methodologically weak, for example because they left out the best models.
The second argument is a forecast about where things are headed, and it forms the heart of the piece. The models are improving fast, while doctors lose their own skills through AI use, as a Lancet study on colonoscopies suggests. The gap should only widen from here.
Once the machine is clearly ahead, the doctor doing the checking turns from a safety net into a source of error. According to the authors, a meta-analysis of 106 experiments backs this up. When the human is better, the combination helps. When the AI is better, the human makes the result worse by overruling the system in the wrong places. In a study using real patient cases, GPT-4 alone scored 92 percent on diagnostic reasoning, while doctors with access to the same model scored just 76 percent.
The authors use chess as a historical parallel: After Deep Blue beat Kasparov in 1997, human-machine teams dominated for years, until AI began beating the teams too starting in 2017.
A warning to the rule writers
From this the piece draws its real message: Locking in guidelines that require a doctor to make the final call could cement a form of care that will soon fall behind. By 2030, the authors expect autonomous AI to be ready for some, maybe many, workflows, limited to cognitive tasks. Liability, payment, regulation, and medical training all need a rethink now, they argue.
There are however limitations to their message, as they admit. Almost all the evidence comes from simulations of single tasks, not real patient care, and the handoff of information between human and model counts as a weak spot.
Physical procedures like surgery, childbirth, and colonoscopies will also stay with humans for now, since the robotics aren't up to it. And autonomous systems fail in ways doctors don't, through hallucinations, internet outages, or cyberattacks. Those risks have to be weighed against the higher accuracy, the authors concede.
AI News Without the Hype – Curated by Humans
Subscribe to THE DECODER for ad-free reading, a weekly AI newsletter, our exclusive "AI Radar" frontier report six times a year, full archive access, and access to our comment section.
Subscribe now
Read on for the full picture.
Subscribe for hype-free coverage.
- Full access to every article on THE DECODER
- No ads
- Join the comments and community discussions
- A weekly AI news recap via mail
- 6x/year: "AI Radar" — deep dives on the AI topics that matter most
- Daily AI news, always up to date
- Our full ten-year archive
- Covered by a team with 10+ years in AI
Subscribe to The Decoder
AIHOT 摘要
《JAMA》发表评论文章预测，自主 AI 在医学推理上将超越任何医生与 AI 的组合，并呼吁监管者不要将人类介入写入规则。作者援引研究称，ChatGPT o3 在 377 个复杂病例中 60% 首先给出正确诊断，而 20 名内科医生仅为 15.9%；GPT-4 单独诊断推理得分 92%，使用同一模型的医生仅 76%。文章预计到 2030 年自主 AI 可胜任部分认知类医疗工作流。
为什么值得关注
它把监管争论从「AI 能否诊断」转到「医生监督何时成为误差源」，用对照实验与棋类历史说明强制人类复核未必安全，对设计人机协作流程的人比诊断分数本身更直接。
工程化解读
从 TopoReduce 的工程视角看，这条信息属于“模型与训练”主题。它的价值不只在于一个新产品或新观点本身，还在于说明 AI 系统正在如何影响模型接入、智能体协作、研发流程、基础设施和团队决策。实际采用前，应结合原文确认版本、适用范围、价格和运行条件。
- 发布时间：2026-08-18；AIHOT 分类：模型与训练。
- AIHOT 标签：
- AIHOT 判断：它把监管争论从「AI 能否诊断」转到「医生监督何时成为误差源」，用对照实验与棋类历史说明强制人类复核未必安全，对设计人机协作流程的人比诊断分数本身更直接。
- AIHOT 评分：64；评分用于站内排序，不等同于独立评测结论。
TopoReduce 编辑观察
当 AI 动态进入真实生产环境，团队需要同时关注能力边界、数据来源、调用成本、权限控制和可回滚性。把单条新闻放回完整工程链路中阅读，比只看标题更有助于判断它是否适合自己的产品和工作流。